Stay up-to-date with the latest news, trends and developments in iPSCs.
Press release: Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial Officer
Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy Treatment
The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models
FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials
Press release: Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO